Efficacy of subcutaneous interferon beta-1a in real-life clinical setting: a long-term multicenter follow-up study

被引：0
|
作者：
Totaro, R. [1 ]
De Luca, G. [2 ]
Danni, M. [3 ]
Pucci, E. [4 ]
Farina, D. [2 ]
Cerqua, R. [3 ]
De Marzi, C. [1 ]
Cerrone, P. [1 ]
Onofrj, M. [2 ]
Provinciali, L. [3 ]
Marini, C. [5 ]
机构：
[1] San Salvatore Hosp, Multiple Sclerosis Ctr, Dept Neurol, Laquila, Italy
[2] Univ Cheti, Multiple Sclerosis Ctr, Dept Neurol, Chieti, Italy
[3] Univ Ancona, Multiple Sclerosis Ctr, Dept Neurol, Ancona, Italy
[4] Osped Macerata, Multiple Sclerosis Ctr, Dept Neurol, Macerata, Italy
[5] Univ Aquila, MESVA, Laquila, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P912
引用
收藏
页码：492 / 493
页数：2
相关论文
共 50 条
  • [1] INTERFERON BETA-1b EFFICACY IN REAL-LIFE CLINICAL SETTING: A LONG-TERM FOLLOW-UP STUDY
    Totaro, Rocco
    Di Carmine, Caterina
    Sciamanna, Samanta
    Marini, Carmine
    Carolei, Antonio
    [J]. NEUROLOGY, 2017, 88
  • [2] Interferon beta-1b efficacy in real-life clinical setting: a long-term follow-up study
    Totaro, R.
    Di Carmine, C.
    Sciamanna, S.
    Carrocci, C.
    Marini, C.
    Carolei, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 788 - 788
  • [3] Peginterferon beta-1a safety and efficacy in real-life clinical setting: a prospective, multicenter follow-up study
    Totaro, R.
    De Luca, G.
    Danni, M.
    Maccarone, B.
    Cacchio, G.
    Maddestra, M.
    Assetta, M.
    D'Andreamatteo, G.
    De Marzi, C.
    Farina, D.
    Cerqua, R.
    Ragno, M.
    Taus, C.
    Guidi, M.
    Di Giuseppe, M.
    Cerrone, P.
    Onofrj, M.
    Provinciali, L.
    Marini, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 909 - 910
  • [4] A comparison of efficacy of subcutaneous interferon beta-1a 44 μg, dimethyl fumarate and fingolimod in the real-life clinical practise, a multicenter observational study
    Pavelek, Z.
    Sobisek, L.
    Horakova, D.
    Valis, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 919 - 920
  • [5] Long-term clinical benefits from subcutaneous interferon-beta-1a: a phased analysis of the PRISMS long-term follow-up study
    Traboulsee, A.
    Li, D.
    Kappos, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2006, 12 : S192 - S192
  • [6] Long-term follow-up of multiple sclerosis patients treated with interferon beta-1a (Avonex®)
    Vermersch, R
    Denève, M
    Waucquier, N
    de Seze, J
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S75 - S75
  • [7] Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up
    Urbani, C.
    Dassie, F.
    Zampetti, B.
    Mioni, R.
    Maffei, P.
    Cozzi, R.
    Bogazzi, F.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (07) : 1733 - 1741
  • [8] Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study
    Antonio Carotenuto
    Teresa Costabile
    Mario De Lucia
    Marcello Moccia
    Fabrizia Falco
    Martina Petruzzo
    Marcello De Angelis
    Cinzia Valeria Russo
    Francesco Saccà
    Roberta Lanzillo
    Vincenzo Brescia Morra
    [J]. Journal of Neurology, 2020, 267 : 1737 - 1743
  • [9] Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-Up
    Niznik, Stanley
    Rapoport, Micha J.
    Avnery, Orly
    Lubetsky, Aharon
    Haj Yahia, Soad
    Ellis, Martin H.
    Agmon-Levin, Nancy
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Calcified subcutaneous nodules: a long-term complication of interferon beta-1a therapy
    Macbeth, A. E.
    Kendall, B. R.
    Smith, A.
    Saldanha, G.
    Harman, K. E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (03) : 624 - 625
12345